日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advancing policy and practice in alcohol-associated liver disease and alcohol-attributable cancer: Correspondence to the editorial on "Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States"

推进酒精相关肝病和酒精相关癌症的政策和实践:对“美国酒精相关肝病中的性别差异和酒精相关癌症的亚型差异”社论的回应

Danpanichkul, Pojsakorn; Kim, Donghee; Wijarnpreecha, Karn; Singal, Amit G; Yang, Ju Dong

Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation

免疫疗法与乐伐替尼治疗晚期肝细胞癌的疗效比较:基于目标试验模拟的真实世界分析

Ahn, Joseph C; Ng, Wee Han; Yeo, Yee Hui; Kim, Hyun-Seok; Wang, Yun; Trivedi, Hirsh; Ayoub, Walid S; Kuo, Alexander; Rich, Nicole; Parikh, Neehar D; Abou-Alfa, Ghassan K; Ma, Kevin Sheng-Kai; Singal, Amit G; Yang, Ju Dong

Unbiased clustering of acute-on-chronic liver failure patients using machine learning in a real-world ICU cohort

利用机器学习技术对真实ICU队列中的急性加慢性肝衰竭患者进行无偏聚类分析

Zhang, Mengyi; Ji, Fanpu; Zu, Jian; He, Yingli; Chen, Tao; Liu, Yi; Trivedi, Hirsh D; Yang, Ju Dong; Sundaram, Vinay; Wang, Yuan; Sun, Xiaodan; Cao, Zhujun; Wu, Chun-Ying; Yeo, Yee Hui; Jalan, Rajiv

Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis

在肝硬化患者中,肝细胞癌筛查期间钆塞酸增强磁共振成像与超声的质量比较

Lewis, Sara; Wildman-Tobriner, Benjamin; Cuevas, Jordan; Calle, Sergio; Bolger, Ian; Wang, Katherine; Joshi, Himanshu; Mankowski Gettle, Lori; Yang, Ju Dong; Min, Ji Hye; Sirlin, Claude B; Reeder, Scott B; Bashir, Mustafa R; Taouli, Bachir

Prickle4 Drives Microenvironmental Remodeling and Resistance to Parp Inhibition in IDH-Mutant Glioma.

Prickle4 驱动 IDH 突变型胶质瘤的微环境重塑和对 Parp 抑制剂的耐药性。

Yang Ju, Yang Hua, Yuan Yifan, Zhang Chenyang, Fu Ziwei, Chen Yanyan, Xiong Yinghong, Chen Shuyu, Ling Kexin, Liu Ying, Huse Jason T, Chen Bo, Chan Timothy A, Qi Zengxin, Zhang Zhao, Liu Xiuping, Wang Yuxiang

Computational frameworks for enhanced extracellular vesicle biomarker discovery

用于增强细胞外囊泡生物标志物发现的计算框架

Kim, Jina; Yang, Ju Dong; Agopian, Vatche G; Zhu, Yazhen; Tseng, Hsian-Rong; You, Sungyong

Dynamic FIB-4 Score Changes and HCC Risk in Patients with MASLD and Elevated Liver Enzymes: A Nationwide Cohort Study

动态 FIB-4 评分变化与 MASLD 合并肝酶升高患者的 HCC 风险:一项全国性队列研究

Yeo, Yee Hui; Ho, Hsiu J; Huang, Tsai-Wei; Lee, Teng-Yu; Yang, Ju Dong; Cholankeril, George; Chen, Chien-Jen; Yang, Hawi-I; Chen, Chuen-Fei; Chang, Hung-Chuen; Wu, Chun-Ying

Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

免疫相关不良事件与肝细胞癌免疫检查点抑制剂治疗后预后改善相关:系统评价和荟萃分析

Hwang, Soo Young; Rezaee-Zavareh, Mohammad Saeid; Attia, Abdelrahman M; Kaymen, Emily A; Tran, Nguyen; Abou-Alfa, Ghassan K; Parikh, Neehar D; Singal, Amit G; Yang, Ju Dong

Senescence-Driven IL-17A Inflammatory Circuit Promotes Epithelial-Mesenchymal Transition (EMT) and Progression in Age-Related Posterior Subcapsular Cataracts

衰老驱动的IL-17A炎症通路促进上皮-间质转化(EMT)和年龄相关性后囊下白内障的进展

Ni, Yan; Ma, Yu; Ren, Zewen; Zhu, Yi; Liu, Liangping; Duan, Runping; Qin, Lu; Chen, Yang; Ju, Rong; Qin, Yingyan; Wu, Mingxing

Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944

更正:Ly 等人,《非核苷类逆转录酶抑制剂依曲韦林通过前梯度蛋白 2 同源物降解抑制卵巢癌转移》,《国际分子科学杂志》,2022 年,23 卷,944 页。

Ly, Thanh Truong Giang; Yun, Jisoo; Ha, Jong-Seong; Kim, Yeon-Ju; Jang, Woong-Bi; Le, Thi Hong Van; Rethineswaran, Vinoth Kumar; Choi, Jaewoo; Kim, Jae-Ho; Min, Sang-Hyun; Lee, Dong-Hyung; Yang, Ju-Seok; Chung, Joo-Seop; Kwon, Sang-Mo